Glucagon News and Research

RSS

Ozempic and similar drugs may lower risks for opioid and alcohol use disorders

A new study published in the scientific journal Addiction has found that people with opioid or alcohol use disorder (OUD, AUD) who take Ozempic or similar medications to treat diabetic/weight-related conditions appear to have a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than people with OUD and AUD who do not take Ozempic or similar medications.

17 Oct 2024

GLP1R medications show promise in reducing suicidal ideation among adolescents with obesity

Adolescents treated with GLP1R drugs for obesity exhibit fewer suicidal thoughts, indicating potential mental health benefits of these medications.

17 Oct 2024

Electronic nudges improve flu vaccination rates in non-diabetic patients but fail to increase uptake in diabetics

Electronic nudges had a small impact on flu vaccine uptake in patients without diabetes but showed no significant effect among diabetic patients, suggesting the need for tailored strategies for this group.

16 Oct 2024

Dietitians boost GLP-1 therapy success with personalized care and side effect management

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients on GLP-1 medications for weight management. The study highlights the critical role of dietitians in guiding lifestyle and dietary changes.

15 Oct 2024

Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models

Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease models, while restoring oxytocin levels in both mice and human brain organoids.

14 Oct 2024

Semaglutide improves heart health and reduces weight in obese patients, but with side effects

Semaglutide significantly reduces cardiovascular events and adverse effects in overweight and obese patients. The study highlights semaglutide's superiority over other GLP-1 agonists for cardiovascular health.

14 Oct 2024

GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation

Research highlights how GLP-1 receptor agonists may improve brain health by targeting the neurovascular unit, linking metabolic health to cognitive function. It suggests potential therapies for neurodegenerative diseases like Alzheimer's.

7 Oct 2024

Study sheds light on a potential new strategy to prevent fatty liver

The accumulation of fats in the liver is driven by high-fat diets and obesity, and is becoming an increasingly prevalent global health concern.

7 Oct 2024

Rice University leads development of innovative bioelectronic implant for obesity and diabetes

Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of a bioelectronic implant designed to improve adherence for obesity and type 2 diabetes (T2D) treatment while reducing development and manufacturing costs.

3 Oct 2024

Nanocapsules for glucagon offer a new approach to prevent hypoglycemia

People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low - from taking too much insulin or not eating enough sugar - people can experience hypoglycemia, which can lead to dizziness, cognitive impairment, seizures or comas.

2 Oct 2024

Experts propose a set of nutrition competencies for medical students and physician trainees

A professionally-diverse panel of medical and nutrition experts have proposed a set of recommended nutrition competencies for medical students and physician trainees.

30 Sep 2024

New treatment strategy targets somatostatin to prevent blood sugar drops in type 1 diabetes

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes.

30 Sep 2024

Regulating iron overload: Liraglutide's potential benefits

Researchers assess the role of liraglutide in regulating iron metabolism in a mouse model of hereditary hemochromatosis.

30 Sep 2024

$Scientists discover potential new treatment for heart failure with preserved ejection fraction$

Scientists discover potential new treatment for heart failure with preserved ejection fraction

Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ejection fraction (HFpEF), a type of heart disease that is notoriously difficult to treat.

30 Sep 2024

Why hypoglycemia-induced glucagon secretion becomes impaired in diabetes

Findings indicate that excessive somatostatin inhibits glucagon secretion in type 1 diabetes, offering a novel target for hypoglycemia management strategies.

27 Sep 2024

12-week coffee compound study shows promising results for weight and fat reduction in at-risk individuals

Cafestol may aid in reducing body weight and visceral fat, but its impact on insulin sensitivity and glucose tolerance remains limited, according to the study.

27 Sep 2024

New pipeline of drug candidates offers hope for effective MASLD treatments

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease (MASLD), has become the most prevalent chronic liver disease globally.

25 Sep 2024

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the National Center for Drug Abuse Statistics.

25 Sep 2024

Semaglutide shows promise in treating chronic skin condition in obese patients

A pioneering study, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity.

24 Sep 2024

New guidelines for cardiovascular management in noncardiac surgery released

The 2024 guideline for cardiovascular management of adults undergoing noncardiac surgery reflects a decade of updates and new evidence since the guideline's last release in 2014.

24 Sep 2024

Glucagon News and Research

Ozempic and similar drugs may lower risks for opioid and alcohol use disorders

GLP1R medications show promise in reducing suicidal ideation among adolescents with obesity

Electronic nudges improve flu vaccination rates in non-diabetic patients but fail to increase uptake in diabetics

Dietitians boost GLP-1 therapy success with personalized care and side effect management

Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models

Semaglutide improves heart health and reduces weight in obese patients, but with side effects

GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation

Study sheds light on a potential new strategy to prevent fatty liver

Rice University leads development of innovative bioelectronic implant for obesity and diabetes

Nanocapsules for glucagon offer a new approach to prevent hypoglycemia

Experts propose a set of nutrition competencies for medical students and physician trainees

New treatment strategy targets somatostatin to prevent blood sugar drops in type 1 diabetes

Regulating iron overload: Liraglutide's potential benefits

Scientists discover potential new treatment for heart failure with preserved ejection fraction

Why hypoglycemia-induced glucagon secretion becomes impaired in diabetes

12-week coffee compound study shows promising results for weight and fat reduction in at-risk individuals

New pipeline of drug candidates offers hope for effective MASLD treatments

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Semaglutide shows promise in treating chronic skin condition in obese patients

New guidelines for cardiovascular management in noncardiac surgery released

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News